RIGGS RORY B - Insider Non-Derivative Transactions at Intra-Cellular Therapies, Inc. (ITCI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 28, 2024, RIGGS RORY B's relationship to Intra-Cellular Therapies, Inc. (ITCI) is Director, and currently has 116,862 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ITCI insiders.
Data Source: SEC.
RIGGS RORY B - Insider Non-Derivative Transactions of ITCI Common Stock
RIGGS RORY B - Insider Non-Derivative Transactions at ITCI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 29, 2024 | Acquisition -- (Common Stock) | 262 | 68.49 | 116862 |
| Jun 25, 2024 | Sell -- (Common Stock) | 4462 | 75.57 | 116600 |
| Jun 25, 2024 | M -- (Common Stock) | 20000 | 16.86 | 121062 |
| Jun 24, 2024 | M -- (Common Stock) | 1567 | 0 | 101062 |
| Apr 1, 2024 | Acquisition -- (Common Stock) | 260 | 69.2 | 99495 |
| Mar 21, 2024 | M -- (Common Stock) | 20000 | 18.56 | 99235 |
| Jan 1, 2024 | Acquisition -- (Common Stock) | 251 | 71.62 | 79235 |
| Oct 1, 2023 | Acquisition -- (Common Stock) | 345 | 52.09 | 78984 |
| Jul 1, 2023 | Acquisition -- (Common Stock) | 279 | 63.32 | 78639 |
| Apr 1, 2023 | Acquisition -- (Common Stock) | 313 | 54.15 | 78360 |
| Dec 31, 2022 | Acquisition -- (Common Stock) | 321 | 52.92 | 78047 |